This review identified that ketamine treatment was associated with instances of elevated liver enzymes.
This review identified that ketamine treatment was associated with instances of elevated liver enzymes.
These data indicate a need to identify and disseminate successful hospital-based strategies to increase prescribing of MAUD.
This study calculated frequencies and measures of central tendency.
These results suggest that MOUD access in supportive housing should be expanding, which could require embedding addiction care into PSH teams, leveraging behavioral health touchpoints, and addressing persistent disparities.
This paper introduces behavioral health, Medicaid, and public health agency leaders, administrators, managers, and policymakers to selected public child- and family-serving systems.
No summary available
Clinicians are rightly expected to disclose their gaps in knowledge or their inability to forecast an outcome. Yet emerging AI tools often cannot, or will not, do the same.
No summary available
This episode examines how pharmacy-based models are closing gaps in addiction care deserts, how pharmacists can strengthen interdisciplinary care teams, and why fair reimbursement for pharmacist services matters for sustaining care in the communities hit hardest by overdose.
No summary available
This talk will provide a background on traditional kratom and an overview of the recent proliferation of novel, kratom-derived products. Industry marketing, confused media coverage, and dynamic government policy will be described, as all influence public health responses.
Respectful communication about mental health is especially important during times of transition, including housing instability or reentry into the community. Compassionate words signal safety when people need it most. #MHAM2026 #MentalHealthAwarenessMonth
AAPP's newest policy brief addresses misinformation about the association between antidepressants and violence, emphasizing the safety and benefits of antidepressants for treating various mental health disorders.
Learn more about the Board of Pharmacy Specialties (BPS) and the Board Certified Psychiatric Pharmacist credential at the BPS web page and YouTube channel.
The AAPP Foundation's Collegiate Chapter Impact Grant Program is designed to support AAPP collegiate chapters at schools of pharmacy across the nation. This is a great opportunity for chapters to receive funding for their projects and activities. The application portal is OPEN and submissions are due Sept. 30, 2025.
Psychiatric pharmacists work in an ever-growing number of diverse practice settings. Explore articles and videos to see some career paths available to psychiatric pharmacists today.
No summary available
No summary available
This toolkit provides a resource for recognizing, understanding, and managing episodes of agitation and forms of aggression encountered in clinical practice.
No summary available
No summary available
No summary available
No summary available
AAPP has committed over $500,000 to directly support research related to the impact of psychiatric pharmacists on patient care through the AAPP Foundation. The commitment has already funded two major prospective research projects.
Extend your visibility and reach through AAPP’s 2026 Virtual Industry Showcase Series. Virtual showcases are promotional activities that do not offer ACPE credit. From May through November, one showcase is available for each month listed below on a first-come, first-serve basis. AAPP offers a total of six showcase opportunities to our industry partners.